VISHEE(SH:688580) Sou Hu Cai Jing·2025-08-01 11:51Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Weisi Medical, indicating a decline in stock price and a relatively lower PE ratio compared to the industry average [1][2] - As of August 1, Weisi Medical's stock closed at 45.5 yuan, down 1.60%, with a rolling PE ratio of 38.41 times and a total market capitalization of 4.358 billion yuan [1] - The average PE ratio for the medical device industry is 53.65 times, with a median of 37.22 times, placing Weisi Medical at the 79th position in the industry ranking [1][2] Group 2 - The latest quarterly report for Q1 2025 shows Weisi Medical achieved a revenue of 95.9127 million yuan, representing a year-on-year increase of 9.40%, and a net profit of 33.2201 million yuan, reflecting a year-on-year growth of 52.71% [1] - The gross profit margin for Weisi Medical stands at 66.65%, indicating strong profitability within its operations [1] - The company has a total of 5,933 shareholders as of March 31, 2025, an increase of 637 shareholders, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]